Boston Scientific's Q1 Outlook Below Expectations Drives Share Price Decline
Boston Scientific (BSX) experienced a significant drop in its stock price during Q1 2026 due to an outlook that fell below expectations, primarily driven by slower revenue growth in the electrophysiology segment. The company's shares closed at $46.92 on June 16, with a one-month return of -17.20% and a 53.71% decline over the past year.
Tickers: $BSX
Topics: investment strategy medical devices stock performance